It is one of the first development pre-clinical tests one does when moving a drug to human testing - ADME. I find it quite preposterous that you'd assume your new optimised lead will follow the same path as earlier compounds. You'd be hard pressed to find any company in the pharmaceutical sphere that would make those sorts of assumptions.
It is one of the first development pre-clinical tests one does...
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $14.38M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.9¢ | 2.7¢ | $9.445K | 348.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21405 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 681148 | 3 |
View Market Depth
| Last trade - 13.13pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.7¢ |
Change
-0.002 ( 3.57 %) |
||||
| Open | High | Low | Volume | ||
| 2.7¢ | 2.7¢ | 2.7¢ | 269805 | ||
| Last updated 13.13pm 03/05/2024 ? | |||||
| 1AD (ASX) Chart |